These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24059368)

  • 1. Hepatocellular carcinoma: perfusion quantification with dynamic contrast-enhanced MRI.
    Taouli B; Johnson RS; Hajdu CH; Oei MT; Merad M; Yee H; Rusinek H
    AJR Am J Roentgenol; 2013 Oct; 201(4):795-800. PubMed ID: 24059368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI?
    Hectors SJ; Wagner M; Besa C; Bane O; Dyvorne HA; Fiel MI; Zhu H; Donovan M; Taouli B
    J Magn Reson Imaging; 2016 Oct; 44(4):856-64. PubMed ID: 26919327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic contrast-enhanced MRI perfusion quantification in hepatocellular carcinoma: comparison of gadoxetate disodium and gadobenate dimeglumine.
    Stocker D; Hectors S; Bane O; Vietti-Violi N; Said D; Kennedy P; Cuevas J; Cunha GM; Sirlin CB; Fowler KJ; Lewis S; Taouli B
    Eur Radiol; 2021 Dec; 31(12):9306-9315. PubMed ID: 34043055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy.
    Chen BB; Hsu CY; Yu CW; Liang PC; Hsu C; Hsu CH; Cheng AL; Shih TT
    Radiology; 2016 Nov; 281(2):454-464. PubMed ID: 27171020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?
    Kurucay M; Kloth C; Kaufmann S; Nikolaou K; Bösmüller H; Horger M; Thaiss WM
    Cancer Imaging; 2017 Jun; 17(1):18. PubMed ID: 28659180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic Contrast-Enhanced Magnetic Resonance Imaging With Gadolinium Ethoxybenzyl Diethylenetriamine Pentaacetic Acid for Quantitative Assessment of Vascular Effects on Hepatocellular-Carcinoma Lesions Treated by Transarterial Chemoembolization or Radiofrequency Ablation.
    Ippolito D; Trattenero C; Talei Franzesi C; Casiraghi A; Lombardi S; Vacirca F; Corso R; Sironi S
    J Comput Assist Tomogr; 2016; 40(5):692-700. PubMed ID: 27560010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating liver perfusion from free-breathing continuously acquired dynamic gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced acquisition with compressed sensing reconstruction.
    Chandarana H; Block TK; Ream J; Mikheev A; Sigal SH; Otazo R; Rusinek H
    Invest Radiol; 2015 Feb; 50(2):88-94. PubMed ID: 25333309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Image quality of mean temporal arterial and mean temporal portal venous phase images calculated from low dose dynamic volume perfusion CT datasets in patients with hepatocellular carcinoma and pancreatic cancer.
    Wang X; Henzler T; Gawlitza J; Diehl S; Wilhelm T; Schoenberg SO; Jin ZY; Xue HD; Smakic A
    Eur J Radiol; 2016 Nov; 85(11):2104-2110. PubMed ID: 27776665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative perfusion imaging of neoplastic liver lesions: A multi-institution study.
    Pahwa S; Liu H; Chen Y; Dastmalchian S; O'Connor G; Lu Z; Badve C; Yu A; Wright K; Chalian H; Rao S; Fu C; Vallines I; Griswold M; Seiberlich N; Zeng M; Gulani V
    Sci Rep; 2018 Mar; 8(1):4990. PubMed ID: 29563601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of optimal scan delay for gadoxetate disodium-enhanced hepatic arterial phase MRI using MR fluoroscopic triggering and slow injection technique.
    Goshima S; Kanematsu M; Kondo H; Watanabe H; Kawada H; Moriyama N; Bae KT
    AJR Am J Roentgenol; 2013 Sep; 201(3):578-82. PubMed ID: 23971449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences Between CT-Perfusion and Biphasic Contrast-enhanced CT for Detection and Characterization of Hepatocellular Carcinoma: Potential Explanations for Discrepant Cases.
    Perl RM; Portugall J; Hinterleitner C; Hinterleitner M; Kloth C; Walter SS; Bitzer M; Horger MS
    Anticancer Res; 2021 Mar; 41(3):1451-1458. PubMed ID: 33788737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma in cirrhotic liver: double-contrast-enhanced, high-resolution 3.0T-MR imaging with pathologic correlation.
    Yoo HJ; Lee JM; Lee MW; Kim SJ; Lee JY; Han JK; Choi BI
    Invest Radiol; 2008 Jul; 43(7):538-46. PubMed ID: 18580337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved hepatic arterial fraction estimation using cardiac output correction of arterial input functions for liver DCE MRI.
    Chouhan MD; Bainbridge A; Atkinson D; Punwani S; Mookerjee RP; Lythgoe MF; Taylor SA
    Phys Med Biol; 2017 Feb; 62(4):1533-1546. PubMed ID: 28002045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of Hepatic Perfusion Using GRASP MRI: Bringing Liver MRI on a New Level.
    Weiss J; Ruff C; Grosse U; Grözinger G; Horger M; Nikolaou K; Gatidis S
    Invest Radiol; 2019 Dec; 54(12):737-743. PubMed ID: 31206392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DCE-MRI of the liver: effect of linear and nonlinear conversions on hepatic perfusion quantification and reproducibility.
    Aronhime S; Calcagno C; Jajamovich GH; Dyvorne HA; Robson P; Dieterich D; Fiel MI; Martel-Laferriere V; Chatterji M; Rusinek H; Taouli B
    J Magn Reson Imaging; 2014 Jul; 40(1):90-8. PubMed ID: 24923476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Added value of breathhold diffusion-weighted MRI in detection of small hepatocellular carcinoma lesions compared with dynamic contrast-enhanced MRI alone using receiver operating characteristic curve analysis.
    Xu PJ; Yan FH; Wang JH; Lin J; Ji Y
    J Magn Reson Imaging; 2009 Feb; 29(2):341-9. PubMed ID: 19161186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of small hepatocellular carcinoma: perfusion quantification and time-concentration curve evaluation using color-coded and quantitative digital subtraction angiography.
    Chen CW; Hsu LS; Weng JC; Weng HH; Ye YL; Hsu SL; Lin WM
    Medicine (Baltimore); 2018 Nov; 97(48):e13392. PubMed ID: 30508937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-spatial and high-temporal resolution dynamic contrast-enhanced perfusion imaging of the liver with time-resolved three-dimensional radial MRI.
    Brodsky EK; Bultman EM; Johnson KM; Horng DE; Schelman WR; Block WF; Reeder SB
    Magn Reson Med; 2014 Mar; 71(3):934-41. PubMed ID: 23519837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic contrast-enhanced MRI to assess hepatocellular carcinoma response to Transarterial chemoembolization using LI-RADS criteria: A pilot study.
    Thibodeau-Antonacci A; Petitclerc L; Gilbert G; Bilodeau L; Olivié D; Cerny M; Castel H; Turcotte S; Huet C; Perreault P; Soulez G; Chagnon M; Kadoury S; Tang A
    Magn Reson Imaging; 2019 Oct; 62():78-86. PubMed ID: 31247250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.